VWF and COVID-19: In this pathological context, vWF, a key coagulation factor formed within endothelial cells and megakaryocytes, has been repeatedly reported elevated in the circulation of COVID-19 patients [47, 48], where it acts as a marker of endotheliopathy and a predictor of poor outcome [49].